Novel biotherapies are needed in youth mental health

Amminger, G. Paul, Berger, Maximus, Rice, Simon M., Davey, Christopher G., Schafer, Miriam R., and McCorry, Patrick D. (2017) Novel biotherapies are needed in youth mental health. Australasian Psychiatry, 25 (2). pp. 117-120.

PDF (Published Version) - Published Version
Restricted to Repository staff only

DOI: 10.1177/1039856217698237

View at Publisher Website: http://doi.org/10.1177/1039856217698237

Abstract

Adverse effects and lack of efficacy in a significant number of patients limit pharmaceutical interventions in youth psychiatry. This is exemplified by the fact that no medication is currently approved for the treatment of non-OCD anxiety disorders or major depressive disorder in young people younger than 18 years of age in Australia. Here, emerging biological therapies for youth with mental health problems are discussed. There is an urgent need for more research into biological interventions with acceptable risk benefit balances. Omega-3 fatty acids, cannabidiol and N-acetylcysteine are currently being evaluated. If initial findings are confirmed, they may offer alternatives with more benign side-effect profiles than existing treatments.


Item ID:	50609
Item Type:	Article (Research - C1)
ISSN:	1440-1665
Keywords:	youth mental health, biotherapies, long-chain omega-3 polyunsaturated fatty acids, cannabidiol, transcranial magnetic stimulation
Funders:	National Health and Medical Research Council of Australia (NHMRC), James Cook University Postgraduate Research Scheme, Royal Melbourne Hospital
Projects and Grants:	NHMRC 1080963, NHMRC 1061757, NHMRC 1060996
Date Deposited:	20 Sep 2017 10:28
FoR Codes:	32 BIOMEDICAL AND CLINICAL SCIENCES > 3202 Clinical sciences > 320221 Psychiatry (incl. psychotherapy) @ 100%
SEO Codes:	92 HEALTH > 9205 Specific Population Health (excl. Indigenous Health) > 920599 Specific Population Health (excl. Indigenous Health) not elsewhere classified @ 100%
	More Statistics

Actions (Repository Staff Only)

Item Control Page